Search

Financial results - GASTRO ONCOLOGY RESEARCH S.R.L.

0.00
Financial Summary - Gastro Oncology Research S.r.l.
Unique identification code: 16611590
Registration number: J40/11597/2004
Nace: 8622
Sales - Ron
57.381
Net Profit - Ron
42.998
Employees
Open Account
Company Gastro Oncology Research S.r.l. with Fiscal Code 16611590 recorded a turnover of 2024 of 57.381, with a net profit of 42.998 and having an average number of employees of - . The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Gastro Oncology Research S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 25.470 23.058 32.757 49.032 62.966 50.300 21.504 23.435 50.555 57.381
Total Income - EUR 25.662 23.064 33.508 49.143 63.647 50.974 21.572 23.435 50.563 57.387
Total Expenses - EUR 14.425 14.860 15.510 9.484 6.375 5.602 8.196 7.166 6.395 6.319
Gross Profit/Loss - EUR 11.237 8.203 17.998 39.660 57.272 45.372 13.375 16.269 44.167 51.068
Net Profit/Loss - EUR 10.467 7.511 16.993 38.186 55.383 43.989 12.728 15.580 37.242 42.998
Employees 0 0 0 0 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 14.1%, from 50.555 euro in the year 2023, to 57.381 euro in 2024. The Net Profit increased by 5.965 euro, from 37.242 euro in 2023, to 42.998 in the last year.
Sales - Ron
Net Profit - Ron
Employees
See Company Data

Check the financial reports for the company - Gastro Oncology Research S.r.l.

Rating financiar

Financial Rating -
GASTRO ONCOLOGY RESEARCH S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Gastro Oncology Research S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Gastro Oncology Research S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Gastro Oncology Research S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Gastro Oncology Research S.r.l. - CUI 16611590

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 21.360 13.890 4.120 1.485 2.503 1.492 3.079 1.948 1.080 1.413
Current Assets 24.550 3.535 17.395 37.624 53.042 44.771 12.414 13.858 38.364 42.054
Inventories 0 0 0 0 0 0 0 0 0 0
Receivables 0 0 10.662 1.199 0 1.590 1.160 254 2.365 3.077
Cash 24.550 3.535 6.733 36.425 53.042 43.181 11.255 13.604 35.999 38.978
Shareholders Funds 10.521 7.565 17.045 38.237 55.434 44.038 12.777 15.628 37.290 43.047
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 35.389 9.860 4.470 872 111 2.224 2.716 178 2.153 421
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 42.054 euro in 2024 which includes Inventories of 0 euro, Receivables of 3.077 euro and cash availability of 38.978 euro.
The company's Equity was valued at 43.047 euro, while total Liabilities amounted to 421 euro. Equity increased by 5.965 euro, from 37.290 euro in 2023, to 43.047 in 2024.
Monitors the Company

Risk Reports Prices

Reviews - Gastro Oncology Research S.r.l.

Comments - Gastro Oncology Research S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.